Oramed Pharmaceuticals Inc.

ORMP

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001176309

SEC filings (opens in a new tab)

No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Oramed Pharmaceuticals Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of ORMP: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Q3 2021	Change
Holders	75	93	+18
Shares	3.84M	5.41M	+1.57M (+40.8%)
Value	$51.4M	$118.9M	+$67.4M (+131.2%)

New holders (25)

Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to ORMP in Q3 2021
Institution	Shares	Value	% of portfolio
Calamos Advisors LLC	132,145	$2.91M	0.01%
Jetstream Capital LLC	120,000	$2.64M	2.88%
Russell Investments Group, Ltd.	102,873	$2.26M	0.00%
EAM Investors, LLC	66,392	$1.46M	0.25%
Sabby Management, LLC	40,344	$887.0K	0.19%
Ameriprise Financial Inc	33,560	$738.0K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	25,854	$568.0K	0.00%
AQR Capital Management LLC	22,571	$496.0K	0.00%
Janney Montgomery Scott LLC	20,478	$450.0K	0.00%
Bank Julius Baer & Co. Ltd, Zurich	20,000	$440.0K	0.00%
Banque Cantonale Vaudoise	20,000	$440.0K	0.02%
Greylin Investment Mangement Inc	18,900	$415.0K	0.08%
SG Americas Securities, LLC	13,541	$298.0K	0.00%
Belvedere Trading LLC	11,972	$269.0K	0.07%
Trexquant Investment LP	11,124	$245.0K	0.02%
Dumont & Blake Investment Advisors LLC	8,050	$177.0K	0.05%
Huntington National Bank	5,002	$110.0K	0.00%
FNY Investment Advisers, LLC	2,195	$48.0K	0.02%
Carroll Financial Associates, Inc.	2,000	$43.0K	0.00%
Proequities, Inc.	1,000	$22.0K	0.00%
Kings Point Capital Management	500	$11.0K	0.00%
Koshinski Asset Management, Inc.	440	$9.67K	0.00%
Covington Capital Management	325	$7.00K	0.00%
Clearstead Advisors, LLC	250	$5.00K	0.00%
Meeder Asset Management Inc	95	$3.00K	0.00%

Sold out (7)

Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of ORMP in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Frontier Wealth Management LLC	72,600	$971.0K
Engineers Gate Manager LP	22,310	$299.0K
National Asset Management, Inc.	20,883	$280.0K
Qube Research & Technologies Ltd	16,407	$220.0K
Advisory Services Network, LLC	500	$7.00K
Federated Hermes, Inc.	439	$6.00K
Panagora Asset Management Inc	411	$5.00K